View drug registration information details.
| Items | Registration information |
|---|
| ID | 1776 |
|---|
| No | 1776 |
|---|
| Brand Name | LUCIQUIZA |
|---|
| Ingredients | QUIZARTINIB 17.7 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 14'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | IN COMBINATION WITH STANDARD CYTARABINE AND ANTHRACYCLINE INDUCTION AD CYTARABINE CONSOLIDATION, AND AS MAINTENANCE MONOTHERAPY FOLLOWING CONSOLIDATION CHEMOTHERAPY, FOR THE TREATMENT OF ADULT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA THAT IS FLT3 INTERNAL TANDERM DUPLICATION POSITIVE. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | IVORY, ROUND, FILM COATED TABLET |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 06 L 1105/24 |
|---|
| FDD Registration Date | 21-JUN-2024 |
|---|
| Expiry Date | 20 JUN 2027 |
|---|
Back to drug list
|
